Conversion therapy for hepatocellular carcinoma: paradigm shifts, unresolved controversies, and translational horizons
iLIVER
· Elsevier
Abstract
Publication date: December 2026 Source: iLIVER, Volume 5, Issue 4 Author(s): Da-Long Yang, Masatoshi Kudo, Tian Yang, Jian-Hong Zhong
Read at publisher →
Citation
Conversion therapy for hepatocellular carcinoma: paradigm shifts, unresolved controversies, and translational horizons. // iLIVER. – URL: https://www.sciencedirect.com/science/article/pii/S2772947826000551?dgcid=rss_sd_all
Conversion therapy for hepatocellular carcinoma: paradigm shifts, unresolved controversies, and translational horizons. iLIVER. https://www.sciencedirect.com/science/article/pii/S2772947826000551?dgcid=rss_sd_all
“Conversion therapy for hepatocellular carcinoma: paradigm shifts, unresolved controversies, and translational horizons.” iLIVER.
@article{article103471,
title = {Conversion therapy for hepatocellular carcinoma: paradigm shifts, unresolved controversies, and translational horizons},
journal = {iLIVER},
url = {https://www.sciencedirect.com/science/article/pii/S2772947826000551?dgcid=rss_sd_all}
}